Yoshiya Horimoto - Search Results

Year	Number of Results
2008	1
2009	2
2011	3
2012	2
2013	2
2014	2
2015	6
2016	7
2017	6
2018	7
2019	5
2020	15
2021	19
2022	11
2023	14
2024	9

1

Azithromycin induces read-through of the nonsense Apc allele and prevents intestinal tumorigenesis in C3B6F1 Apc^Min/+ mice.

Semba R, Morioka T, Yanagihara H, Suzuki K, Tachibana H, Hamoya T, Horimoto Y, Imaoka T, Saito M, Kakinuma S, Arai M. Semba R, et al. Among authors: horimoto y. Biomed Pharmacother. 2023 Aug;164:114968. doi: 10.1016/j.biopha.2023.114968. Epub 2023 Jun 3. Biomed Pharmacother. 2023. PMID: 37276642 Free article.

2

Emerging roles of the tumor-associated stroma in promoting tumor metastasis.

Horimoto Y, Polanska UM, Takahashi Y, Orimo A. Horimoto Y, et al. Cell Adh Migr. 2012 May-Jun;6(3):193-202. doi: 10.4161/cam.20631. Epub 2012 May 1. Cell Adh Migr. 2012. PMID: 22568980 Free PMC article. Review.

3

Molecular Characteristics of Lymphocyte-predominant Triple-negative Breast Cancer.

Sasaki R, Horimoto Y, Yanai Y, Kurisaki-Arakawa A, Arakawa A, Nakai K, Saito M, Saito T. Sasaki R, et al. Among authors: horimoto y. Anticancer Res. 2021 Apr;41(4):2133-2140. doi: 10.21873/anticanres.14985. Anticancer Res. 2021. PMID: 33813424

4

Involvement of kallikrein-PAR2-proinflammatory pathway in severe trastuzumab-induced cardiotoxicity.

Sasaki R, Kurebayashi N, Eguchi H, Horimoto Y, Shiga T, Miyazaki S, Kashiyama T, Akamatsu W, Saito M. Sasaki R, et al. Among authors: horimoto y. Cancer Sci. 2022 Oct;113(10):3449-3462. doi: 10.1111/cas.15508. Epub 2022 Aug 19. Cancer Sci. 2022. PMID: 35879248 Free PMC article.

5

Intrinsic subtype distribution should vary according to institutions.

Horimoto Y, Tanabe M. Horimoto Y, et al. Breast. 2020 Dec;54:349. doi: 10.1016/j.breast.2020.11.004. Epub 2020 Nov 10. Breast. 2020. PMID: 33199215 Free PMC article. No abstract available.

6

Pathology of healing: what else might we look at?

Horimoto Y, Hayashi T, Arakawa A. Horimoto Y, et al. Cancer Med. 2016 Dec;5(12):3586-3587. doi: 10.1002/cam4.952. Epub 2016 Oct 26. Cancer Med. 2016. PMID: 27781408 Free PMC article.

7

Emerging measurements for tumor-infiltrating lymphocytes in breast cancer.

Wu R, Horimoto Y, Oshi M, Benesch MGK, Khoury T, Takabe K, Ishikawa T. Wu R, et al. Among authors: horimoto y. Jpn J Clin Oncol. 2024 Mar 23:hyae033. doi: 10.1093/jjco/hyae033. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 38521965

8

Tamoxifen-resistant breast cancer cells exhibit reactivity with Wisteria floribunda agglutinin.

Hlaing MT, Horimoto Y, Denda-Nagai K, Fujihira H, Noji M, Kaji H, Tomioka A, Ishizuka Y, Saeki H, Arakawa A, Saito M, Irimura T. Hlaing MT, et al. Among authors: horimoto y. PLoS One. 2022 Aug 25;17(8):e0273513. doi: 10.1371/journal.pone.0273513. eCollection 2022. PLoS One. 2022. PMID: 36006984 Free PMC article.

9

Impact of Diabetes on Patient Outcomes in Breast Cancer Patients.

Tobe A, Horimoto Y, Kobayashi K, Kamisada N, Hirano M. Tobe A, et al. Among authors: horimoto y. Breast Care (Basel). 2022 Oct;17(5):480-485. doi: 10.1159/000524513. Epub 2022 Apr 11. Breast Care (Basel). 2022. PMID: 36684403 Free PMC article.

10

Is adjuvant chemotherapy necessary in older patients with breast cancer?

Morita M, Shimomura A, Tokuda E, Horimoto Y, Kawamura Y, Ishizuka Y, Sekine K, Obayashi S, Kojima Y, Uemura Y, Higuchi T. Morita M, et al. Among authors: horimoto y. Breast Cancer. 2022 May;29(3):498-506. doi: 10.1007/s12282-021-01329-7. Epub 2022 Jan 15. Breast Cancer. 2022. PMID: 35032302 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year